Transcriptomics Market Report

Global Transcriptomics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：186
  • REPORT CODE：GMM851038
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Transcriptomics market report explains the definition, types, applications, major countries, and major players of the Transcriptomics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Fluidigm Corporation

    • F Hoffmann-La Roche

    • Thermo Fisher Scientific

    • Agilent Technologies

    • Merck

    • Illumina

    • Promega Corporation

    • QIAGEN (Exiqon)

    • Bio-Rad Laboratories

    • GE Healthcare Dharmacon

    By Type:

    • Real Time-PCR (qPCR)

    • Microarray

    • Sequencing

    By End-User:

    • Government Institutes & Academic Centers

    • Pharmaceutical & Biotechnology Companies

    • Contract research Organizations (CROs)

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Transcriptomics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Transcriptomics Outlook to 2028- Original Forecasts

    • 2.2 Transcriptomics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Transcriptomics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Transcriptomics Market- Recent Developments

    • 6.1 Transcriptomics Market News and Developments

    • 6.2 Transcriptomics Market Deals Landscape

    7 Transcriptomics Raw Materials and Cost Structure Analysis

    • 7.1 Transcriptomics Key Raw Materials

    • 7.2 Transcriptomics Price Trend of Key Raw Materials

    • 7.3 Transcriptomics Key Suppliers of Raw Materials

    • 7.4 Transcriptomics Market Concentration Rate of Raw Materials

    • 7.5 Transcriptomics Cost Structure Analysis

      • 7.5.1 Transcriptomics Raw Materials Analysis

      • 7.5.2 Transcriptomics Labor Cost Analysis

      • 7.5.3 Transcriptomics Manufacturing Expenses Analysis

    8 Global Transcriptomics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Transcriptomics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Transcriptomics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Transcriptomics Market Outlook by Types and Applications to 2022

    • 9.1 Global Transcriptomics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Real Time-PCR (qPCR) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Microarray Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Sequencing Consumption and Growth Rate (2017-2022)

    • 9.2 Global Transcriptomics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Government Institutes & Academic Centers Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Contract research Organizations (CROs) Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Transcriptomics Market Analysis and Outlook till 2022

    • 10.1 Global Transcriptomics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Transcriptomics Consumption (2017-2022)

      • 10.2.2 Canada Transcriptomics Consumption (2017-2022)

      • 10.2.3 Mexico Transcriptomics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Transcriptomics Consumption (2017-2022)

      • 10.3.2 UK Transcriptomics Consumption (2017-2022)

      • 10.3.3 Spain Transcriptomics Consumption (2017-2022)

      • 10.3.4 Belgium Transcriptomics Consumption (2017-2022)

      • 10.3.5 France Transcriptomics Consumption (2017-2022)

      • 10.3.6 Italy Transcriptomics Consumption (2017-2022)

      • 10.3.7 Denmark Transcriptomics Consumption (2017-2022)

      • 10.3.8 Finland Transcriptomics Consumption (2017-2022)

      • 10.3.9 Norway Transcriptomics Consumption (2017-2022)

      • 10.3.10 Sweden Transcriptomics Consumption (2017-2022)

      • 10.3.11 Poland Transcriptomics Consumption (2017-2022)

      • 10.3.12 Russia Transcriptomics Consumption (2017-2022)

      • 10.3.13 Turkey Transcriptomics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Transcriptomics Consumption (2017-2022)

      • 10.4.2 Japan Transcriptomics Consumption (2017-2022)

      • 10.4.3 India Transcriptomics Consumption (2017-2022)

      • 10.4.4 South Korea Transcriptomics Consumption (2017-2022)

      • 10.4.5 Pakistan Transcriptomics Consumption (2017-2022)

      • 10.4.6 Bangladesh Transcriptomics Consumption (2017-2022)

      • 10.4.7 Indonesia Transcriptomics Consumption (2017-2022)

      • 10.4.8 Thailand Transcriptomics Consumption (2017-2022)

      • 10.4.9 Singapore Transcriptomics Consumption (2017-2022)

      • 10.4.10 Malaysia Transcriptomics Consumption (2017-2022)

      • 10.4.11 Philippines Transcriptomics Consumption (2017-2022)

      • 10.4.12 Vietnam Transcriptomics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Transcriptomics Consumption (2017-2022)

      • 10.5.2 Colombia Transcriptomics Consumption (2017-2022)

      • 10.5.3 Chile Transcriptomics Consumption (2017-2022)

      • 10.5.4 Argentina Transcriptomics Consumption (2017-2022)

      • 10.5.5 Venezuela Transcriptomics Consumption (2017-2022)

      • 10.5.6 Peru Transcriptomics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Transcriptomics Consumption (2017-2022)

      • 10.5.8 Ecuador Transcriptomics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Transcriptomics Consumption (2017-2022)

      • 10.6.2 Kuwait Transcriptomics Consumption (2017-2022)

      • 10.6.3 Oman Transcriptomics Consumption (2017-2022)

      • 10.6.4 Qatar Transcriptomics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Transcriptomics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Transcriptomics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Transcriptomics Consumption (2017-2022)

      • 10.7.2 South Africa Transcriptomics Consumption (2017-2022)

      • 10.7.3 Egypt Transcriptomics Consumption (2017-2022)

      • 10.7.4 Algeria Transcriptomics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Transcriptomics Consumption (2017-2022)

      • 10.8.2 New Zealand Transcriptomics Consumption (2017-2022)

    11 Global Transcriptomics Competitive Analysis

    • 11.1 Fluidigm Corporation

      • 11.1.1 Fluidigm Corporation Company Details

      • 11.1.2 Fluidigm Corporation Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Fluidigm Corporation Transcriptomics Main Business and Markets Served

      • 11.1.4 Fluidigm Corporation Transcriptomics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 F Hoffmann-La Roche

      • 11.2.1 F Hoffmann-La Roche Company Details

      • 11.2.2 F Hoffmann-La Roche Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 F Hoffmann-La Roche Transcriptomics Main Business and Markets Served

      • 11.2.4 F Hoffmann-La Roche Transcriptomics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Thermo Fisher Scientific

      • 11.3.1 Thermo Fisher Scientific Company Details

      • 11.3.2 Thermo Fisher Scientific Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Thermo Fisher Scientific Transcriptomics Main Business and Markets Served

      • 11.3.4 Thermo Fisher Scientific Transcriptomics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Agilent Technologies

      • 11.4.1 Agilent Technologies Company Details

      • 11.4.2 Agilent Technologies Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Agilent Technologies Transcriptomics Main Business and Markets Served

      • 11.4.4 Agilent Technologies Transcriptomics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Merck

      • 11.5.1 Merck Company Details

      • 11.5.2 Merck Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Merck Transcriptomics Main Business and Markets Served

      • 11.5.4 Merck Transcriptomics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Illumina

      • 11.6.1 Illumina Company Details

      • 11.6.2 Illumina Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Illumina Transcriptomics Main Business and Markets Served

      • 11.6.4 Illumina Transcriptomics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Promega Corporation

      • 11.7.1 Promega Corporation Company Details

      • 11.7.2 Promega Corporation Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Promega Corporation Transcriptomics Main Business and Markets Served

      • 11.7.4 Promega Corporation Transcriptomics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 QIAGEN (Exiqon)

      • 11.8.1 QIAGEN (Exiqon) Company Details

      • 11.8.2 QIAGEN (Exiqon) Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 QIAGEN (Exiqon) Transcriptomics Main Business and Markets Served

      • 11.8.4 QIAGEN (Exiqon) Transcriptomics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Bio-Rad Laboratories

      • 11.9.1 Bio-Rad Laboratories Company Details

      • 11.9.2 Bio-Rad Laboratories Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Bio-Rad Laboratories Transcriptomics Main Business and Markets Served

      • 11.9.4 Bio-Rad Laboratories Transcriptomics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 GE Healthcare Dharmacon

      • 11.10.1 GE Healthcare Dharmacon Company Details

      • 11.10.2 GE Healthcare Dharmacon Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 GE Healthcare Dharmacon Transcriptomics Main Business and Markets Served

      • 11.10.4 GE Healthcare Dharmacon Transcriptomics Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Transcriptomics Market Outlook by Types and Applications to 2028

    • 12.1 Global Transcriptomics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Real Time-PCR (qPCR) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Microarray Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Transcriptomics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Government Institutes & Academic Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Contract research Organizations (CROs) Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Transcriptomics Market Analysis and Outlook to 2028

    • 13.1 Global Transcriptomics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Transcriptomics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Transcriptomics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Transcriptomics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.2 UK Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.5 France Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Transcriptomics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Transcriptomics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.3 India Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Transcriptomics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Transcriptomics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Transcriptomics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Transcriptomics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Transcriptomics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Transcriptomics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Transcriptomics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Transcriptomics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Transcriptomics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Transcriptomics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Transcriptomics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Transcriptomics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Transcriptomics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Transcriptomics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Transcriptomics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Transcriptomics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Transcriptomics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Transcriptomics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Transcriptomics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Transcriptomics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Transcriptomics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Transcriptomics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Transcriptomics

    • Figure of Transcriptomics Picture

    • Table Global Transcriptomics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Transcriptomics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Real Time-PCR (qPCR) Consumption and Growth Rate (2017-2022)

    • Figure Global Microarray Consumption and Growth Rate (2017-2022)

    • Figure Global Sequencing Consumption and Growth Rate (2017-2022)

    • Figure Global Government Institutes & Academic Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Contract research Organizations (CROs) Consumption and Growth Rate (2017-2022)

    • Figure Global Transcriptomics Consumption by Country (2017-2022)

    • Table North America Transcriptomics Consumption by Country (2017-2022)

    • Figure United States Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Canada Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Transcriptomics Consumption and Growth Rate (2017-2022)

    • Table Europe Transcriptomics Consumption by Country (2017-2022)

    • Figure Germany Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure UK Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Spain Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure France Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Italy Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Finland Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Norway Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Poland Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Russia Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Transcriptomics Consumption and Growth Rate (2017-2022)

    • Table APAC Transcriptomics Consumption by Country (2017-2022)

    • Figure China Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Japan Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure India Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Transcriptomics Consumption and Growth Rate (2017-2022)

    • Table South America Transcriptomics Consumption by Country (2017-2022)

    • Figure Brazil Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Chile Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Peru Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Transcriptomics Consumption and Growth Rate (2017-2022)

    • Table GCC Transcriptomics Consumption by Country (2017-2022)

    • Figure Bahrain Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Oman Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Transcriptomics Consumption and Growth Rate (2017-2022)

    • Table Africa Transcriptomics Consumption by Country (2017-2022)

    • Figure Nigeria Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Transcriptomics Consumption and Growth Rate (2017-2022)

    • Table Oceania Transcriptomics Consumption by Country (2017-2022)

    • Figure Australia Transcriptomics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Transcriptomics Consumption and Growth Rate (2017-2022)

    • Table Fluidigm Corporation Company Details

    • Table Fluidigm Corporation Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fluidigm Corporation Transcriptomics Main Business and Markets Served

    • Table Fluidigm Corporation Transcriptomics Product Portfolio

    • Table F Hoffmann-La Roche Company Details

    • Table F Hoffmann-La Roche Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Transcriptomics Main Business and Markets Served

    • Table F Hoffmann-La Roche Transcriptomics Product Portfolio

    • Table Thermo Fisher Scientific Company Details

    • Table Thermo Fisher Scientific Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Transcriptomics Main Business and Markets Served

    • Table Thermo Fisher Scientific Transcriptomics Product Portfolio

    • Table Agilent Technologies Company Details

    • Table Agilent Technologies Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Agilent Technologies Transcriptomics Main Business and Markets Served

    • Table Agilent Technologies Transcriptomics Product Portfolio

    • Table Merck Company Details

    • Table Merck Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Transcriptomics Main Business and Markets Served

    • Table Merck Transcriptomics Product Portfolio

    • Table Illumina Company Details

    • Table Illumina Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Transcriptomics Main Business and Markets Served

    • Table Illumina Transcriptomics Product Portfolio

    • Table Promega Corporation Company Details

    • Table Promega Corporation Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Promega Corporation Transcriptomics Main Business and Markets Served

    • Table Promega Corporation Transcriptomics Product Portfolio

    • Table QIAGEN (Exiqon) Company Details

    • Table QIAGEN (Exiqon) Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN (Exiqon) Transcriptomics Main Business and Markets Served

    • Table QIAGEN (Exiqon) Transcriptomics Product Portfolio

    • Table Bio-Rad Laboratories Company Details

    • Table Bio-Rad Laboratories Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories Transcriptomics Main Business and Markets Served

    • Table Bio-Rad Laboratories Transcriptomics Product Portfolio

    • Table GE Healthcare Dharmacon Company Details

    • Table GE Healthcare Dharmacon Transcriptomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Dharmacon Transcriptomics Main Business and Markets Served

    • Table GE Healthcare Dharmacon Transcriptomics Product Portfolio

    • Figure Global Real Time-PCR (qPCR) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microarray Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sequencing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Government Institutes & Academic Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical & Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Contract research Organizations (CROs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transcriptomics Consumption Forecast by Country (2022-2028)

    • Table North America Transcriptomics Consumption Forecast by Country (2022-2028)

    • Figure United States Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Transcriptomics Consumption Forecast by Country (2022-2028)

    • Figure Germany Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Transcriptomics Consumption Forecast by Country (2022-2028)

    • Figure China Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Transcriptomics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Transcriptomics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Transcriptomics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Transcriptomics Consumption Forecast by Country (2022-2028)

    • Figure Australia Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Transcriptomics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US